PRME
NASDAQ · Biotechnology
Prime Medicine Inc
$3.21
+0.10 (+3.05%)
PRME News2 articles
Primerica Beats Q1 Forecasts, Investment Sales Surge Offsets Life Insurance Dip
Primerica topped Q1 earnings estimates with $5.96 per share, driven by record investment product sales, though new life insurance policies declined 14%.
Credit Divide Deepens: Super-Prime Borrowers Surge While Lower Tiers Face Rising Debt Burdens
TransUnion data reveals a widening credit gap: super-prime borrowers increased by 15 million since 2019, while near-prime and subprime consumers face rising debt-to-income ratios and higher delinquency rates.